honokiol has been researched along with Liver Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Serie, MM; Darwish, AI; Haiba, NS; Khalil, HH; Khattab, SN; Osman, HA; Teleb, M | 1 |
| Choe, W; Ha, J; Jeong, S; Kang, I; Kim, KY; Kim, S; Lee, YS; Yoon, JS; Yoon, KS | 1 |
| Basoli, V; Carta, P; Cruciani, S; Delogu, G; Dettori, MA; Fabbri, D; Maioli, M; Serra, PA | 1 |
| Li, H; Pu, H; Sun, Q; Tang, B; Tang, P; Yang, H | 1 |
| Dang, L; Dong, CL; Xiao, G; Yang, R | 1 |
| Chang, YF; Chen, HC; Chi, CW; Hsia, CY; Hsu, HT; Lee, HC; Weng, JW | 1 |
| Abbasi, T; Ahn, KS; Kapoor, S; Kumar, AP; Li, F; Rajendran, P; Sethi, G; Shanmugam, MK; Vali, S | 1 |
| Arbiser, J; Arlt, MJ; Banke, IJ; Born, W; Fuchs, B; Langsam, B; Muff, R; Steinmann, P; Walters, DK; Ziegler, U | 1 |
| Katiyar, SK; Prasad, R; Singh, T | 1 |
9 other study(ies) available for honokiol and Liver Neoplasms
| Article | Year |
|---|---|
Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular Carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dendrimers; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lignans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Molecular Structure; Structure-Activity Relationship; Triazines | 2021 |
Honokiol inhibits hepatoma carcinoma cell migration through downregulated Cyclophilin B expression.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Survival; Cyclophilins; Down-Regulation; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Lignans; Liver Neoplasms; Signal Transduction | 2021 |
Synthesis of magnolol and honokiol derivatives and their effect against hepatocarcinoma cells.
Topics: Biphenyl Compounds; Carbon-13 Magnetic Resonance Spectroscopy; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Lignans; Liver Neoplasms; Proton Magnetic Resonance Spectroscopy | 2018 |
Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Carcinoma, Hepatocellular; Catechin; Cell Proliferation; Chitin; Cross-Linking Reagents; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Liberation; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Kinetics; Lignans; Liver Neoplasms; Male; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Nanoparticles; Nanotechnology; Particle Size; Solubility; Surface Properties; Technology, Pharmaceutical; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
[Study on effect and mechanism of Honokiol enhancing tumor necrosis factor-related apoptosis inducing ligand against hepatocellular carcinoma HepG2 cells via activating JNK signaling pathway].
Topics: Animals; Apoptosis; Biphenyl Compounds; Carcinoma, Hepatocellular; Cell Line, Tumor; Hep G2 Cells; Humans; Lignans; Liver Neoplasms; MAP Kinase Signaling System; Mice; Mice, Nude; TNF-Related Apoptosis-Inducing Ligand | 2018 |
Combined effect of honokiol and rosiglitazone on cell growth inhibition through enhanced G0/G1 phase arrest in hepatoma cells.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; G1 Phase Cell Cycle Checkpoints; Humans; Lignans; Liver Neoplasms; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2016 |
Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; CSK Tyrosine-Protein Kinase; G1 Phase; Genes, Reporter; Humans; Interleukin-6; Janus Kinase 1; Janus Kinase 2; Lignans; Liver Neoplasms; Models, Biological; Poly(ADP-ribose) Polymerases; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor | 2012 |
Antimetastatic activity of honokiol in osteosarcoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Bone Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Lignans; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred C3H; Osteosarcoma | 2012 |
Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo.
Topics: Acetylation; Animals; Biphenyl Compounds; Bronchi; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Epithelial Cells; G1 Phase Cell Cycle Checkpoints; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Hydroxamic Acids; Lignans; Liver Neoplasms; Mice; Mice, Nude; Proteasome Endopeptidase Complex; Proteolysis; Valproic Acid; Xenograft Model Antitumor Assays | 2013 |